RANI Rani Therapeutics Holdings, Inc.

Fundamentals / CIK 0001856725 / USD

Rani Therapeutics Holdings, Inc. reported $6.58M in revenue and a net loss of $32.46M for the trailing twelve months ended September 30, 2026 (up 58.9% year over year), with a -530.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RANI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$6.27M$3.13M$0-$31.99MFY 2020 Revenue: $462KFY 2020 Net Income: -$16.70M2020FY 2021 Revenue: $2.72MFY 2021 Net Income: -$8.33M2021FY 2022 Revenue: $0FY 2022 Net Income: -$30.59M2022FY 2023 Revenue: $0FY 2023 Net Income: -$33.97M2023FY 2024 Revenue: $1.03MFY 2024 Net Income: -$30.02M2024FY 2025 Revenue: $1.63MFY 2025 Net Income: -$29.67M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.63M $1.03M $0 $0 $2.72M $462K
Research & Development $20.20M $26.68M $39.62M $36.61M $26.48M $12.04M
Total Operating Expenses $39.94M $54.34M $66.10M $63.45M $54.32M -$17.01M
Operating Income -$38.31M -$53.31M -$66.10M -$63.45M -$51.60M -$16.54M
EBITDA -$37.41M -$52.29M -$65.28M -$62.90M -$51.10M -$15.96M
Interest Income -- -- -- -- $89K $63K
Interest Expense $2.89M $5.03M $5.08M $1.07M $466K $124K
Income Before Tax -- -- -$67.88M -$63.27M -$53.05M -$16.67M
Income Tax Expense $0 $0 $0 $70K $41K $35K
Net Income -$29.67M -$30.02M -$33.97M -$30.59M -$8.33M -$16.70M
Basic EPS -$0.45 -$1.05 -$1.33 -$1.28 -$0.43 --
Diluted EPS -$0.45 -$1.05 -$1.33 -$1.28 -$0.43 --
Basic Shares Outstanding 66.1K 28.5K 25.5K 23.8K 19.5K --
Diluted Shares Outstanding 66.1K 28.5K 25.5K 23.8K 19.5K --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.71M $1.71M $1.71M $1.46M $0 $0 $172K $1.03M
Research & Development $6.02M $5.02M $5.16M $4.91M $3.22M $5.50M $6.57M $6.81M
Total Operating Expenses $10.93M $10.54M $10.05M $10.00M $7.26M $10.51M $12.19M $15.99M
Operating Income -$9.22M -$8.83M -$8.34M -$8.54M -$7.26M -$10.51M -$12.01M -$14.96M
EBITDA -$9.10M -$8.68M -$8.18M -$8.35M -$7.03M -$10.27M -$11.76M -$14.69M
Interest Expense $43K $8.0K $88K $347K $725K $877K $943K $1.12M
Net Income -$7.73M -$7.39M -$7.03M -$10.30M -$5.41M -$6.69M -$7.26M -$8.95M
Basic EPS -$0.04 -$0.04 -$0.04 -- -$0.12 -$0.18 -$0.22 --
Diluted EPS -$0.04 -$0.04 -$0.04 -- -$0.12 -$0.18 -$0.22 --
Basic Shares Outstanding 199.0M 187.2M 180.0M -- 46.4M 36.5M 33.4M --
Diluted Shares Outstanding 199.0M 187.2M 180.0M -- 46.4M 36.5M 33.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $18.62M $3.76M $5.86M $27.01M $117.5M $73.06M
Short-Term Investments -- -- -- $98.50M -- --
Cash & Short-Term Investments $18.62M $3.76M $5.86M $125.5M $117.5M $73.06M
Accounts Receivable, Net $2.04M $0 -- -- -- --
Total Current Assets $53.32M $29.74M $50.85M $100.9M $119.6M $74.94M
Property, Plant & Equipment, Net $736K $1.55M $6.11M $6.04M $4.61M $4.47M
Other Non-Current Assets $246K $246K $246K $0 -- --
Total Non-Current Assets $5.30M $6.89M $7.07M $7.10M $4.61M $4.47M
Total Assets $58.62M $36.63M $57.92M $108.0M $124.2M $79.42M
Accounts Payable $309K $1.36M $648K $1.46M $1.08M $537K
Short-Term Debt $0 $15.00M $4.90M $0 -- $1.36M
Deferred Revenue (Current) $6.83M $0 -- -- -- $2.72M
Total Current Liabilities $12.67M $19.89M $7.99M $4.82M $2.64M $5.31M
Long-Term Debt $0 $9.61M $24.48M $29.15M $0 $2.41M
Deferred Revenue (Non-Current) $1.71M $0 -- -- -- --
Total Non-Current Liabilities $4.44M $13.25M $24.48M $29.21M $0 $2.73M
Total Liabilities $17.11M $33.14M $32.47M $34.02M $2.64M $8.04M
Total Debt (incl. Leases) $4.32M $29.71M $30.10M $30.21M $0 $3.77M
Common Stock -- -- -- -- -- $0
Retained Earnings -$132.6M -$102.9M -$72.89M -$38.92M -$8.33M -$114.0M
Accumulated Other Comp. Income $1.0K $5.0K -$12K -$73K $0 --
Total Stockholders' Equity $33.01M $1.99M $12.87M $36.85M $47.41M -$113.3M
Total Equity $41.51M $3.49M $25.44M $74.00M $121.6M -$113.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.62M $4.87M $9.64M $18.62M $4.14M $10.22M $10.11M $3.76M
Cash & Short-Term Investments $3.62M $4.87M $9.64M $18.62M $4.14M $10.22M $10.11M $3.76M
Accounts Receivable, Net $1.96M $2.04M $2.04M $2.04M -- -- $600K $0
Total Current Assets $48.48M $56.52M $47.09M $53.32M $4.96M $11.07M $17.78M $29.74M
Property, Plant & Equipment, Net $659K $525K $601K $736K $922K $1.14M $1.35M $1.55M
Other Non-Current Assets $246K $246K $246K $246K $245K $293K $246K $246K
Total Non-Current Assets $4.05M $4.32M $4.79M $5.30M $5.18M $5.83M $6.34M $6.89M
Total Assets $52.53M $60.84M $51.88M $58.62M $10.14M $16.90M $24.12M $36.63M
Accounts Payable $454K $1.05M $858K $309K $2.47M $1.80M $1.52M $1.36M
Short-Term Debt -- -- -- $0 $13.54M $15.00M $15.00M $15.00M
Deferred Revenue (Current) $3.42M $5.12M $6.83M $6.83M -- -- -- $0
Total Current Liabilities $9.22M $10.64M $13.86M $12.67M $19.14M $20.62M $20.13M $19.89M
Long-Term Debt -- -- -- $0 $0 $2.23M $5.92M $9.61M
Deferred Revenue (Non-Current) $0 $0 $0 $1.71M -- -- -- $0
Total Non-Current Liabilities $1.95M $2.22M $2.48M $4.44M $2.97M $5.43M $9.34M $13.25M
Total Liabilities $11.18M $12.86M $16.34M $17.11M $22.11M $26.05M $29.47M $33.14M
Total Debt (incl. Leases) $3.15M $3.55M $3.94M $4.32M $17.55M $21.62M $25.67M $29.71M
Retained Earnings -$154.7M -$147.0M -$139.6M -$132.6M -$122.3M -$116.9M -$110.2M -$102.9M
Accumulated Other Comp. Income -$57K -$30K -$8.0K $1.0K $3.0K $3.0K $2.0K $5.0K
Total Stockholders' Equity $33.97M $39.23M $28.41M $33.01M -$7.86M -$5.58M -$3.06M $1.99M
Total Equity $41.35M $47.98M $35.54M $41.51M -$11.97M -$9.15M -$5.35M $3.49M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$40.95M -$56.58M -$67.88M -$63.34M -$53.09M -$16.70M
Depreciation & Amortization $900K $1.03M $822K $548K $497K $589K
Stock-Based Compensation $11.80M $16.03M $19.01M $15.78M $22.59M $0
Change in Receivables -$2.04M $0 -- -- -- --
Change in Payables -$1.05M $711K -$595K $163K $543K $933K
Operating Cash Flow -$18.71M -$35.50M -$51.24M -$46.52M -$32.24M -$14.96M
Capital Expenditure -$88K -$268K -$1.23M -$1.62M -$506K -$1.20M
Free Cash Flow -$18.80M -$35.76M -$52.47M -$48.13M -$32.75M -$16.16M
Purchases of Investments -$33.69M -$57.47M -$73.26M -$73.82M $0 --
Investing Cash Flow -$7.03M $19.81M $29.86M -$72.44M -$506K -$1.20M
Common Stock Issued -- -- -- -- $71.10M --
Financing Cash Flow $40.30M $13.59M $233K $29.00M $77.15M $72.68M
Net Change in Cash $14.56M -$2.10M -$21.14M -$89.95M $44.40M $56.52M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$8.81M -$8.42M -$8.02M -$9.07M -$7.91M -$11.22M -$12.74M -$15.72M
Depreciation & Amortization $123K $152K $161K $186K $223K $240K $251K $266K
Stock-Based Compensation $2.21M $2.42M $2.08M $2.24M $2.34M $3.29M $3.92M $3.99M
Change in Receivables -- $0 $0 -$2.47M $0 $1.03M -$600K $0
Change in Payables -$263K -$204K $549K -$2.16M $669K $278K $161K -$207K
Operating Cash Flow -$7.76M -$9.03M -$6.50M $294K -$5.06M -$5.80M -$8.15M -$8.65M
Capital Expenditure -$183K -$32K -$15K $0 $0 -$37K -$51K -$31K
Free Cash Flow -$7.94M -$9.06M -$6.51M $294K -$5.06M -$5.83M -$8.20M -$8.69M
Purchases of Investments -$15.05M -$34.48M -$23.43M -$30.97M $0 $0 -$2.72M -$17.75M
Investing Cash Flow $6.86M -$14.56M -$2.45M -$30.97M $0 $5.71M $18.23M $2.52M
Financing Cash Flow -$347K $18.81M -$27K $44.85M -$1.01M $188K -$3.73M $5.62M
Net Change in Cash -$1.25M -$4.78M -$8.97M $14.17M -$6.07M $105K $6.35M -$515K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -2346.0% -5186.2% -- -- -1899.1% -3581.0%
Net Profit Margin -1817.1% -2920.0% -- -- -306.6% -3615.4%
Return on Equity (ROE) -89.9% -1506.9% -264.0% -83.0% -17.6% --
Return on Assets (ROA) -50.6% -81.9% -58.7% -28.3% -6.7% -21.0%
Current Ratio 4.21x 1.50x 6.36x 20.96x 45.30x 14.12x
Quick Ratio 1.63x 0.19x 0.73x 26.07x 44.49x 13.76x
Debt to Equity 0.13x 14.91x 2.34x 0.82x 0.00x --
Revenue Growth (YoY) +58.9% -- -- -100.0% +488.1% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -530.5% -675.8% -1093.0% -2346.0% -3727.8% -4106.2% -4274.5% -5186.3%
Net Profit Margin -493.0% -618.0% -929.1% -1817.1% -2359.6% -2473.8% -2483.2% -2920.0%
Return on Equity (ROE) -95.5% -76.8% -103.7% -89.9% -- -- -- -1506.9%
Return on Assets (ROA) -61.8% -49.5% -56.8% -50.6% -279.3% -175.7% -123.5% -81.9%
Current Ratio 5.26x 5.31x 3.40x 4.21x 0.26x 0.54x 0.88x 1.50x
Quick Ratio 0.61x 0.65x 0.84x 1.63x 0.22x 0.50x 0.53x 0.19x
Debt to Equity 0.09x 0.09x 0.14x 0.13x -- -- -- 14.91x
Revenue Growth (YoY) -- -- +893.0% +42.1% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001856725) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal